MAT1A and liver cancer: MAT1A loss results in reduced SAM synthesis, which is a feature of both cirrhosis and HCC that leads to global hypomethylation in rat livers during hepatocarcinogenesis, and is associated with increased proliferation in human liver cancer cells [76, 77].